Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Peptide-based glioma-targeted drug delivery vector gHoPe2.

Eriste E, Kurrikoff K, Suhorutšenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel Ü.

Bioconjug Chem. 2013 Mar 20;24(3):305-13. doi: 10.1021/bc300370w. Epub 2013 Feb 19.

PMID:
23350661
2.

Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.

Gao H, Yang Z, Zhang S, Cao S, Pang Z, Yang X, Jiang X.

J Control Release. 2013 Dec 28;172(3):921-8. doi: 10.1016/j.jconrel.2013.10.002. Epub 2013 Oct 11.

PMID:
24120853
3.

Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.

Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q.

J Control Release. 2011 Jun 30;152(3):402-10. doi: 10.1016/j.jconrel.2011.03.014. Epub 2011 Mar 22.

PMID:
21435361
4.

Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.

Xia H, Gu G, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Song Q, Yao L, Tu Y, Chen H, Gao X, Chen J.

Bioconjug Chem. 2013 Mar 20;24(3):419-30. doi: 10.1021/bc300520t. Epub 2013 Feb 11.

PMID:
23350619
5.

Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.

Gao H, Zhang S, Cao S, Yang Z, Pang Z, Jiang X.

Mol Pharm. 2014 Aug 4;11(8):2755-63. doi: 10.1021/mp500113p. Epub 2014 Jul 1.

PMID:
24983928
6.

Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.

Zong T, Mei L, Gao H, Cai W, Zhu P, Shi K, Chen J, Wang Y, Gao F, He Q.

Mol Pharm. 2014 Jul 7;11(7):2346-57. doi: 10.1021/mp500057n. Epub 2014 Jun 11.

PMID:
24893333
7.

A stabilized peptide ligand for multifunctional glioma targeted drug delivery.

Ying M, Shen Q, Zhan C, Wei X, Gao J, Xie C, Yao B, Lu W.

J Control Release. 2016 Dec 10;243:86-98. doi: 10.1016/j.jconrel.2016.09.035. Epub 2016 Sep 29.

PMID:
27693752
8.

UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.

Zhang B, Zhang Y, Liao Z, Jiang T, Zhao J, Tuo Y, She X, Shen S, Chen J, Zhang Q, Jiang X, Hu Y, Pang Z.

Biomaterials. 2015 Jan;36:98-109.

PMID:
25443789
9.
10.

Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.

Zhang L, Zhang Y, Tai L, Jiang K, Xie C, Li Z, Lin YZ, Wei G, Lu W, Pan W.

Acta Biomater. 2016 Sep 15;42:90-101. doi: 10.1016/j.actbio.2016.06.031. Epub 2016 Jun 29.

PMID:
27370905
11.

F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.

Hu Q, Gu G, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, Yao L, Xia H, Chen H, Jiang X, Gao X, Chen J.

Biomaterials. 2013 Jan;34(4):1135-45. doi: 10.1016/j.biomaterials.2012.10.048. Epub 2012 Nov 10.

PMID:
23146434
12.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
13.

Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.

Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR.

Mol Cancer Ther. 2006 Dec;5(12):3162-9.

14.

Choline transporter-targeting and co-delivery system for glioma therapy.

Li J, Guo Y, Kuang Y, An S, Ma H, Jiang C.

Biomaterials. 2013 Dec;34(36):9142-8. doi: 10.1016/j.biomaterials.2013.08.030. Epub 2013 Aug 28.

PMID:
23993342
15.

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR.

Biomaterials. 2013 May;34(16):4137-49. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.

PMID:
23453200
16.

Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS.

Neuro Oncol. 2006 Jul;8(3):205-14. Epub 2006 May 24.

17.

Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.

Liu Y, Mei L, Xu C, Yu Q, Shi K, Zhang L, Wang Y, Zhang Q, Gao H, Zhang Z, He Q.

Theranostics. 2016 Jan 1;6(2):177-91. doi: 10.7150/thno.13532. eCollection 2016.

18.

A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.

Zennami K, Yoshikawa K, Kondo E, Nakamura K, Upsilonamada Y, De Velasco MA, Tanaka M, Uemura H, Shimazui T, Akaza H, Saga S, Ueda R, Honda N.

Oncol Rep. 2011 Aug;26(2):327-33. doi: 10.3892/or.2011.1290. Epub 2011 Apr 29.

PMID:
21567093
19.

Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.

Lu RM, Chang YL, Chen MS, Wu HC.

Biomaterials. 2011 Apr;32(12):3265-74. doi: 10.1016/j.biomaterials.2010.12.061.

PMID:
21306768
20.

Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.

Li Y, Zheng X, Gong M, Zhang J.

Oncotarget. 2016 Nov 29;7(48):79401-79407. doi: 10.18632/oncotarget.12708.

Supplemental Content

Support Center